Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: TechSci Research | PRODUCT CODE: 1970696

Cover Image

PUBLISHER: TechSci Research | PRODUCT CODE: 1970696

Asthma Monitoring Device Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Device, By End-User, By Region & Competition, 2021-2031F

PUBLISHED:
PAGES: 181 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4500
PDF and Excel (Multi-User License)
USD 5500
PDF and Excel (Custom Research License)
USD 8000

Add to Cart

We offer 8 hour analyst time for an additional research. Please contact us for the details.

The Global Asthma Monitoring Device Market is projected to expand from USD 302.98 Million in 2025 to USD 436.15 Million by 2031, registering a CAGR of 6.26%. This sector is defined by specialized instruments such as smart inhalers and peak flow meters, which are essential for assessing lung function and tracking respiratory symptoms. Growth is primarily propelled by the rising global incidence of chronic respiratory conditions and the increasing integration of remote patient management technologies, factors that generate a consistent demand for reliable disease control solutions rather than temporary market fluctuations.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 302.98 MIllion
Market Size 2031USD 436.15 MIllion
CAGR 2026-20316.26%
Fastest Growing SegmentSmart Inhalers
Largest MarketNorth America

Despite this positive trajectory, the market faces significant hurdles due to the high costs associated with advanced digital monitoring systems and the lack of adequate reimbursement policies in emerging economies. Data from the Global Initiative for Asthma indicates that over 260 million people worldwide suffered from the disease in 2024, highlighting a critical need for affordable monitoring options. Currently, economic constraints prevent a substantial portion of this patient population from accessing modern technological aids, thereby limiting broader market penetration.

Market Driver

The increasing prevalence of asthma and other chronic respiratory diseases acts as the central force propelling the monitoring device market, particularly in regions burdened by environmental issues. In 2024, the American Lung Association reported that roughly 131.2 million people in the United States resided in areas with unhealthy pollution levels, creating an urgent necessity for rigorous symptom tracking to mitigate health risks. Furthermore, the Asthma and Allergy Foundation of America's 'Asthma Capitals 2024 Report' revealed that nearly 28 million Americans are living with asthma, underscoring the immense scale of the demand for continuous home-based monitoring solutions.

Parallel to this demand, technological innovation in smart inhalers and digital health platforms is revolutionizing the industry by enabling proactive, data-centric care. These modern devices integrate seamlessly with cloud systems to monitor medication adherence in real-time, greatly enhancing patient self-management. This trend is reflected in AstraZeneca's 2024 Annual Report, which noted a 23% revenue increase in their Respiratory & Immunology division, signaling strong industrial growth driven by the adoption of connected care ecosystems that reduce hospital readmissions and improve clinical decision-making.

Market Challenge

A primary obstacle restricting the growth of the Global Asthma Monitoring Device Market is the prohibitive cost of advanced digital monitoring systems combined with limited reimbursement frameworks. Although these technologies provide superior tracking capabilities, their high price points make them inaccessible to a large demographic, especially in emerging economies where patients often rely on out-of-pocket payments. Consequently, when faced with financial constraints, patients typically prioritize purchasing essential medications over acquiring supplementary monitoring tools, effectively preventing the market from realizing its full volume potential across less affluent populations.

The gravity of this economic barrier is further illuminated by the substantial financial burden asthma places on healthcare systems and individuals. According to the Asthma and Allergy Foundation of America, the annual economic cost of asthma in the United States exceeded $82 billion in 2024. This immense figure underscores the strain on the healthcare ecosystem, making it challenging for payers and providers to justify the additional expense of high-end monitoring devices without comprehensive insurance support, thereby stalling market expansion in cost-sensitive regions.

Market Trends

The market is witnessing a fundamental shift toward the Integration of Artificial Intelligence for Predictive Exacerbation Analytics, moving beyond reactive symptom recording to proactive disease forecasting. Advanced algorithms now analyze respiratory patterns to predict attacks before physical symptoms appear, facilitating preemptive interventions that reduce hospitalization risks. For instance, MPO Magazine reported in December 2024 that a new non-contact device by Albus Health utilizes AI to detect early warning signs and predict asthma exacerbations up to five days in advance, transforming monitoring tools into critical early-warning systems.

Simultaneously, the Integration of Real-Time Patient Data into Electronic Health Records is enhancing accessibility by utilizing passive digital markers within existing medical infrastructures. This approach leverages routinely collected health data to identify risk levels without necessitating expensive standalone hardware for every patient, thus circumventing economic barriers. As highlighted by Docwire News in July 2025, a study of nearly 70,000 children demonstrated that passive digital markers could predict asthma risks more accurately than traditional methods, effectively democratizing advanced monitoring and enabling scalable disease management.

Key Market Players

  • COSMED srl.
  • Teleflex Incorporated.
  • SCHILLER.
  • Hill-Rom, Inc.
  • Koninklijke Philips N.V.
  • ICU Medical, Inc.
  • SDI Diagnostics
  • AstraZeneca plc.
  • Merck & Co., Inc

Report Scope

In this report, the Global Asthma Monitoring Device Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Asthma Monitoring Device Market, By Device

  • Spirometer
  • Smart Inhalers
  • Peak Flow Meter

Asthma Monitoring Device Market, By End-User

  • Hospitals & Clinics
  • Homecare
  • Diagnostic Laboratories

Asthma Monitoring Device Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Asthma Monitoring Device Market.

Available Customizations:

Global Asthma Monitoring Device Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Product Code: 20032

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Asthma Monitoring Device Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Device (Spirometer, Smart Inhalers, Peak Flow Meter)
    • 5.2.2. By End-User (Hospitals & Clinics, Homecare, Diagnostic Laboratories)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Asthma Monitoring Device Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Device
    • 6.2.2. By End-User
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Asthma Monitoring Device Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Device
        • 6.3.1.2.2. By End-User
    • 6.3.2. Canada Asthma Monitoring Device Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Device
        • 6.3.2.2.2. By End-User
    • 6.3.3. Mexico Asthma Monitoring Device Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Device
        • 6.3.3.2.2. By End-User

7. Europe Asthma Monitoring Device Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Device
    • 7.2.2. By End-User
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Asthma Monitoring Device Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Device
        • 7.3.1.2.2. By End-User
    • 7.3.2. France Asthma Monitoring Device Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Device
        • 7.3.2.2.2. By End-User
    • 7.3.3. United Kingdom Asthma Monitoring Device Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Device
        • 7.3.3.2.2. By End-User
    • 7.3.4. Italy Asthma Monitoring Device Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Device
        • 7.3.4.2.2. By End-User
    • 7.3.5. Spain Asthma Monitoring Device Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Device
        • 7.3.5.2.2. By End-User

8. Asia Pacific Asthma Monitoring Device Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Device
    • 8.2.2. By End-User
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Asthma Monitoring Device Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Device
        • 8.3.1.2.2. By End-User
    • 8.3.2. India Asthma Monitoring Device Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Device
        • 8.3.2.2.2. By End-User
    • 8.3.3. Japan Asthma Monitoring Device Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Device
        • 8.3.3.2.2. By End-User
    • 8.3.4. South Korea Asthma Monitoring Device Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Device
        • 8.3.4.2.2. By End-User
    • 8.3.5. Australia Asthma Monitoring Device Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Device
        • 8.3.5.2.2. By End-User

9. Middle East & Africa Asthma Monitoring Device Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Device
    • 9.2.2. By End-User
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Asthma Monitoring Device Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Device
        • 9.3.1.2.2. By End-User
    • 9.3.2. UAE Asthma Monitoring Device Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Device
        • 9.3.2.2.2. By End-User
    • 9.3.3. South Africa Asthma Monitoring Device Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Device
        • 9.3.3.2.2. By End-User

10. South America Asthma Monitoring Device Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Device
    • 10.2.2. By End-User
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Asthma Monitoring Device Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Device
        • 10.3.1.2.2. By End-User
    • 10.3.2. Colombia Asthma Monitoring Device Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Device
        • 10.3.2.2.2. By End-User
    • 10.3.3. Argentina Asthma Monitoring Device Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Device
        • 10.3.3.2.2. By End-User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Asthma Monitoring Device Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. COSMED srl.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Teleflex Incorporated.
  • 15.3. SCHILLER.
  • 15.4. Hill-Rom, Inc.
  • 15.5. Koninklijke Philips N.V.
  • 15.6. ICU Medical, Inc.
  • 15.7. SDI Diagnostics
  • 15.8. AstraZeneca plc.
  • 15.9. Merck & Co., Inc

16. Strategic Recommendations

17. About Us & Disclaimer

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!